Browsing by Subject "radiation therapy"
Results Per Page
Sort Options
Item Open Access A current perspective on stereotactic body radiation therapy for pancreatic cancer.(Onco Targets Ther, 2016) Hong, Julian C; Czito, Brian G; Willett, Christopher G; Palta, ManishaPancreatic cancer is a formidable malignancy with poor outcomes. The majority of patients are unable to undergo resection, which remains the only potentially curative treatment option. The management of locally advanced (unresectable) pancreatic cancer is controversial; however, treatment with either chemotherapy or chemoradiation is associated with high rates of local tumor progression and metastases development, resulting in low survival rates. An emerging local modality is stereotactic body radiation therapy (SBRT), which uses image-guided, conformal, high-dose radiation. SBRT has demonstrated promising local control rates and resultant quality of life with acceptable rates of toxicity. Over the past decade, increasing clinical experience and data have supported SBRT as a local treatment modality. Nevertheless, additional research is required to further evaluate the role of SBRT and improve upon the persistently poor outcomes associated with pancreatic cancer. This review discusses the existing clinical experience and technical implementation of SBRT for pancreatic cancer and highlights the directions for ongoing and future studies.Item Open Access Incorporating Case-Based Reasoning for Radiation Therapy Knowledge Modeling: A Pelvic Case Study.(Technology in cancer research & treatment, 2019-01) Sheng, Yang; Zhang, Jiahan; Wang, Chunhao; Yin, Fang-Fang; Wu, Q Jackie; Ge, YaorongKnowledge models in radiotherapy capture the relation between patient anatomy and dosimetry to provide treatment planning guidance. When treatment schemes evolve, existing models struggle to predict accurately. We propose a case-based reasoning framework designed to handle novel anatomies that are of same type but vary beyond original training samples. A total of 105 pelvic intensity-modulated radiotherapy cases were analyzed. Eighty cases were prostate cases while the other 25 were prostate-plus-lymph-node cases. We simulated 4 scenarios: Scarce scenario, Semiscarce scenario, Semiample scenario, and Ample scenario. For the Scarce scenario, a multiple stepwise regression model was trained using 85 cases (80 prostate, 5 prostate-plus-lymph-node). The proposed workflow started with evaluating the feature novelty of new cases against 5 training prostate-plus-lymph-node cases using leverage statistic. The case database was composed of a 5-case dose atlas. Case-based dose prediction was compared against the regression model prediction using sum of squared residual. Mean sum of squared residual of case-based and regression predictions for the bladder of 13 identified outliers were 0.174 ± 0.166 and 0.459 ± 0.508, respectively (P = .0326). For the rectum, the respective mean sum of squared residuals were 0.103 ± 0.120 and 0.150 ± 0.171 for case-based and regression prediction (P = .1972). By retaining novel cases, under the Ample scenario, significant statistical improvement was observed over the Scarce scenario (P = .0398) for the bladder model. We expect that the incorporation of case-based reasoning that judiciously applies appropriate predictive models could improve overall prediction accuracy and robustness in clinical practice.Item Embargo Investigation of Normal Tissue Response to FLASH Irradiation Using the HIGS Linear Accelerator at TUNL(2024) Kay, Tyler VuongPurpose: FLASH irradiation shows strong potential for clinical applications, offering tumor control comparable to conventional irradiation with lower levels of normal tissue toxicity. This combination of effects, the FLASH effect, could widen the therapeutic gap and improve the effectiveness of radiation therapy treatments of cancer and other diseases. While the FLASH effect is typically seen at mean dose rates (MDRs) above 40 Gy/s, the exact conditions for it are unknown. Furthermore, the underlying mechanisms are unclear, with current theories suggesting that FLASH irradiation induces transient hypoxia in normal tissue and causes reduced DNA damage. Duke University is in a unique position to investigate both the conditions and mechanisms behind the FLASH effect through the High Intensity Gamma-ray Source (HIGS) linear accelerator at the Triangle Universities Nuclear Laboratory (TUNL). This FLASH source has been combined with a unique ex vivo rat brain slice organotypic model to create a novel FLASH experimental platform. This platform has been demonstrated to reduce tumor burden, a key component of the FLASH effect. However, the normal tissue sparing portion of the FLASH effect has not been explored. The purpose of this work is to assess independent methods for measuring normal tissue health in the rat brain slice organotypic model and determine if a normal tissue sparing effect is present in this experimental setup.
Methods: Two main experiments were conducted: an experiment using the HIGS linac, and an experiment using a Varian 2100EX clinical linac to replicate the HIGS experiment at a conventional clinical dose rate. For the HIGS irradiation, nine well-plates, each with eight 350-micron thick rat brain slices, were divided into one unirradiated (No IR) and two experimental arms. Plates for each of the experimental arms were irradiated with 4 pulses of 35 MeV electrons from the HIGS linac. One experimental arm, the FLASH arm, was irradiated with 0.15 seconds in-between pulses; the other arm, the non-FLASH arm, was irradiated with 10 seconds in-between pulses. EBT-XD film was scanned using an EPSON 11000XL scanner to determine the dose delivered to each slice. Each treatment arm had a plate dedicated to one of three independent normal tissue health assays: yellow fluorescent protein (YFP), immunofluorescence, or cytokines. Depending on the assay, the slices in the plate either underwent YFP transfection of neurons pre-irradiation, were fixed and underwent immunofluorescence staining three days post-irradiation, or were fixed and underwent cytokine collection three days post-irradiation. Stereoscope images of YFP slices were taken over five days post-irradiation. Healthy neurons were manually tracked to determine surviving fractions for each arm, and YFP intensity was measured for each arm. Confocal images of immunofluorescent slices were taken, with microglia morphology and intensity measurements made with a custom CellProfiler pipeline. Morphology measurements of microglia included: area, perimeter, circularity, eccentricity, mean radius, median radius, major and minor axis lengths, and maximum and minimum Feret diameters. Intensity measurements included integrated intensity, mean intensity, and median intensity. The mean for each measurement was determined for each arm, and ANOVA tests were used to determine statistically significant differences between treatment arm means. Astrocyte branches were also segmented using a separate CellProfiler pipeline to measure total intensity, total intensity per unit area, mean intensity, and mean intensity per unit area for the segmented regions. ANOVA tests were performed to determine statistical significance between treatment arm means. Cytokine profiles were analyzed by Eve Technologies (Alberta, CA), and statistical significance determined using ANOVA tests. The conventional experiment replicated the dose delivered to the FLASH arm for two cytokine plates and an immunofluorescent plate and followed similar analysis methods.Results: Both the YFP-based surviving fraction measurements and the YFP signal intensity measurements could not effectively distinguish between different treatment arms. Both FLASH and CONV irradiation resulted in an increase in microglia size between the irradiated and non-irradiated arms based on area, perimeter, major and minor axis lengths, and maximum and minimum Feret diameter measurements (p < 0.0001). Microglia from the FLASH arm were larger compared with all other irradiated arms based off area, perimeter, major and minor axis lengths, and maximum and minimum Feret diameters (p < 0.05 to p < 0.0001), suggesting increased activation. This is further supported by a higher integrated intensity compared with the non-FLASH and HIGS No IR arms (p < 0.0001). No statistically significant difference was determined between treatment arms with astrocyte analysis. Increased levels of TNF-alpha in the FLASH arm compared with all other arms suggested activation of microglia into a pro-inflammatory M1 state (p < 0.01 to p < 0.0001). Increased levels of fractalkine in the FLASH arm compared with all other arms suggested the transition of microglia from the pro-inflammatory M1 state into an anti-inflammatory, restorative M2 state (p < 0.01 to p < 0.0001).
Conclusions: Any differences present in the YFP assay were below the sensitivity detection threshold of the assay. Microglia immunofluorescence and cytokine profile assays proved effective in detecting differences between treatment arms. Astrocyte analysis was not sensitive enough to distinguish between the different treatment arms. The increased size of microglia, TNF-alpha levels, and fractalkine levels in the FLASH arm compared with other arms suggest a stronger transition from a short-term pro-inflammatory state to an anti-inflammatory state compared with other treatment arms. Together, these results indicate differences in normal tissue response between treatment arms and suggests the possible presence of a normal tissue sparing effect.
Item Open Access Radiation therapy for primary cutaneous γδ T-cell lymphoma: Case report and literature review.(JAAD case reports, 2019-07) Kelsey, Chris R; Wang, Endi; Stefanovic, Alexandra; Kheterpal, MeenalItem Open Access Targeting cell surface-associated GRP78 enhances pancreatic cancer radiosensitivity by reducing YAP/TAZ protein signaling.(The Journal of biological chemistry, 2019-07-29) Gopal, Udhayakumar; Mowery, Yvonne; Young, Kenneth; Pizzo, Salvatore VincentIonizing radiation (IR) can promote migration and invasion of cancer cells, but the basis for this phenomenon has not been fully elucidated. IR increases expression of glucose-regulated protein 78kDa (GRP78) on the surface of cancer cells (CS-GRP78), and this up-regulation is associated with more aggressive behavior, radioresistance, and recurrence of cancer. Here, using various biochemical and immunological methods, including flow cytometry, cell proliferation and migration assays, Rho activation and quantitative RT-PCR assays, we investigated the mechanism by which CS-GRP78 contributes to radioresistance in pancreatic ductal adenocarcinoma (PDAC) cells. We found that activated α2-Macroglobulin (α2M*) a ligand of the CS-GRP78 receptor, induces formation of the AKT kinase (AKT)/DLC1 Rho-GTPase-activating protein (DLC1) complex and thereby increases Rho activation. Further, CS-GRP78 activated the transcriptional coactivators Yes-associated protein (YAP) and tafazzin (TAZ) in a Rho-dependent manner, promoting motility and invasiveness of PDAC cells. We observed that radiation-induced CS-GRP78 stimulates the nuclear accumulation of YAP/TAZ and increases YAP/TAZ target gene expressions. Remarkably, targeting CS-GRP78 with C38 monoclonal antibody (Mab) enhanced radiosensitivity and increased the efficacy of radiation therapy by curtailing PDAC cell motility and invasion. These findings reveal that CS-GRP78 acts upstream of YAP/TAZ signaling and promote migration and radiation-resistance in PDAC cells. We therefore conclude that, C38 Mab is a promising candidate for use in combination with radiation therapy to manage PDAC.